Cytek BioSciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 17.17 M | $86.72 M | 3.78% | 13.46% |
| VANGUARD GROUP INC | 01/29/2026 | 7.48 M | $37.75 M | 7.82% | 5.86% |
| TOPLINE CAPITAL MANAGEMENT, LLC | 02/17/2026 | 7.44 M | $37.58 M | 7.17% | 5.84% |
| HHLR ADVISORS, LTD. | 02/17/2026 | 6.66 M | $33.62 M | 0.00% | 5.22% |
| BOSTON PARTNERS | 02/13/2026 | 5.01 M | $25.30 M | 13,369.35% | 3.93% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 4.75 M | $24.00 M | 39.03% | 3.73% |
| STATE STREET CORP | 02/13/2026 | 4.15 M | $20.94 M | 1.53% | 3.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.79 M | $14.10 M | 0.26% | 2.19% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 2.65 M | $13.37 M | -17.74% | 2.08% |
| BROWN CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.07 M | $10.47 M | -58.19% | 1.63% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.79 M | $9.04 M | 3.03% | 1.40% |
| MORGAN STANLEY | 02/13/2026 | 1.70 M | $8.59 M | 16.26% | 1.33% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 1.69 M | $8.55 M | -4.00% | 1.33% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.09 M | $5.53 M | -0.95% | 0.86% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 1.00 M | $5.06 M | 527.61% | 0.78% |
| NORTHERN TRUST CORP | 02/17/2026 | 957.59 K | $4.84 M | -5.52% | 0.75% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 856.16 K | $4.32 M | 403.15% | 0.67% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 764.28 K | $3.86 M | -69.92% | 0.60% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 743.46 K | $3.75 M | -27.10% | 0.58% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 675.00 K | $3.41 M | -15.15% | 0.53% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 674.48 K | $3.40 M | 19.26% | 0.53% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 666.93 K | $3.37 M | 7.00% | 0.52% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 637.93 K | $3.22 M | -5.29% | 0.50% |
| UBS GROUP AG | 01/29/2026 | 460.05 K | $2.32 M | -1.84% | 0.36% |
| HRT FINANCIAL LP | 02/12/2026 | 437.65 K | $2.21 M | 100.00% | 0.34% |
| INVESCO LTD. | 02/19/2026 | 398.80 K | $2.01 M | 2.49% | 0.31% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 379.27 K | $1.92 M | -11.14% | 0.30% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 361.68 K | $1.83 M | 0.11% | 0.28% |
| JPMORGAN CHASE & CO | 02/11/2026 | 328.85 K | $1.66 M | -8.33% | 0.26% |
| 02/04/2026 | 298.46 K | $1.51 M | 100.00% | 0.23% | |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 295.64 K | $1.49 M | -0.75% | 0.23% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 284.64 K | $1.44 M | 2.76% | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 264.18 K | $1.33 M | -67.96% | 0.21% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 263.13 K | $1.33 M | 117.42% | 0.21% |
| NUVEEN, LLC | 02/12/2026 | 253.81 K | $1.28 M | 0.00% | 0.20% |
| RHUMBLINE ADVISERS | 02/13/2026 | 249.94 K | $1.26 M | -10.85% | 0.20% |
| FMR LLC | 02/17/2026 | 234.07 K | $1.18 M | 29.47% | 0.18% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 202.32 K | $1.02 M | -38.44% | 0.16% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 188.47 K | $951.76 K | -2.03% | 0.15% |
| NUMERAI GP LLC | 02/17/2026 | 186.76 K | $943.16 K | 75.37% | 0.15% |
| BARCLAYS PLC | 02/13/2026 | 183.24 K | $925.36 K | 10.67% | 0.14% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/17/2026 | 168.56 K | $851.24 K | -50.16% | 0.13% |
| CITADEL ADVISORS LLC | 02/17/2026 | 166.75 K | $842.11 K | 102.61% | 0.13% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 141.05 K | $712.29 K | -5.75% | 0.11% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 132.68 K | $670.01 K | 46.76% | 0.10% |
| IEQ CAPITAL, LLC | 02/13/2026 | 123.99 K | $626.16 K | -18.87% | 0.10% |
| CREATIVE PLANNING | 02/17/2026 | 121.21 K | $612.11 K | 11.58% | 0.10% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 114.26 K | $576.99 K | -39.10% | 0.09% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 106.86 K | $539.63 K | -5.16% | 0.08% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 106.28 K | $536.72 K | 346.26% | 0.08% |
Cytek BioSciences Inc institutional Ownership - FAQ's
During the previous two years, 187 institutional investors and hedge funds held shares of Cytek BioSciences Inc. The most heavily invested institutionals were:
Boston Partners: 5.8 M
DIMENSIONAL FUND ADVISORS LP: 2.66 M
ROYCE & ASSOCIATES LP: 1.64 M
Russell Investments Group, Ltd.: 1.36 M
CenterBook Partners LP: 729,874
VANGUARD FIDUCIARY TRUST CO: 717,011
64.31% of Cytek BioSciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 101.84 M shares in the last 24 months. This purchase volume represents approximately $444.03 M in transactions.